We have a PhD student position open focusing on yet mysterious isoform of CIP2A NOCIVA that is clinically very relevant in AML, but whether this is true in breast cancer, and how, this is the question?
https://ats.talentadore.com/apply/vaitoskirjatutkijan-tehtava-westermarckin-tutkimusryhmassa-turun-yliopistossa/D4vabP?lang=en&UTUID=21488